Sherif Kamal, Consultant to the Chairman of the Board of the Egypt Healthcare and Authority Director Medication Management and, shared a post on Facebook:
“Honored to contribute as Vice President – ESOP Glibal, Speaker, and Scientific Committee Member at the 2nd Hematology Oncology Pharmacy Summit (HOPS 2026), Dubai.
At this summit, the discussion went far beyond therapies — it focused on how oncology pharmacy must evolve to safely operationalize advanced and high-risk innovations while preserving value, access, and patient outcomes.
My lecture: Operational Excellence in Oncology Pharmacy for Advanced Therapies
This session addressed the real-world execution gap we face with CAR-T, BiTEs, and ADCs — not at the level of science, but at the level of systems, workflows, and governance.
Key takeaways:
- Translating complex therapies into safe, scalable pharmacy operations
- Risk-based models for handling ultra-high-cost and high-toxicity agents
- Pharmacy’s role in minimizing waste, preventing errors, and protecting outcomes
- Moving oncology pharmacists from “process followers” to clinical and operational decision-makers
My workshop: From Genes to Cure: Genomics Transforming Oncology
This was a deeply interactive, case-based workshop focusing on clinical integration, not theory.
We explored:
- How genomics, biomarkers, and NGS actually change treatment decisions
- Where pharmacists add the highest value in precision oncology pathways
- Avoiding the common trap of “testing without interpretation”
- Preparing pharmacy teams for a future driven by AI, real-time genomics, and personalized care
Core message I emphasized throughout:
Innovation without operational readiness creates risk.
Precision medicine without pharmacy leadership creates fragmentation.
Oncology pharmacists are no longer support players — we are stewards of safety, value, and clinical intelligence across the cancer care continuum.
Grateful to the organizers, scientific colleagues, and engaged participants for the depth of dialogue and the shared commitment to advancing oncology pharmacy practice globally.”
More posts featuring Sherif Kamal.
